0001104659-24-076423.txt : 20240628
0001104659-24-076423.hdr.sgml : 20240628
20240628181246
ACCESSION NUMBER: 0001104659-24-076423
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240619
FILED AS OF DATE: 20240628
DATE AS OF CHANGE: 20240628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kyme Pierre
CENTRAL INDEX KEY: 0002028892
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37544
FILM NUMBER: 241087283
MAIL ADDRESS:
STREET 1: 5005 MCCONNELL AVENUE
CITY: LOS ANGELES
STATE: CA
ZIP: 90066
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Armata Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0000921114
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 911549568
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5005 MCCONNELL AVE
CITY: LOS ANGELES
STATE: CA
ZIP: 90066
BUSINESS PHONE: 310-665-2928
MAIL ADDRESS:
STREET 1: 5005 MCCONNELL AVE
CITY: LOS ANGELES
STATE: CA
ZIP: 90066
FORMER COMPANY:
FORMER CONFORMED NAME: AmpliPhi Biosciences Corp
DATE OF NAME CHANGE: 20130222
FORMER COMPANY:
FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/
DATE OF NAME CHANGE: 19940331
3
1
tm2418494-1_3seq1.xml
OWNERSHIP DOCUMENT
X0206
3
2024-06-19
0
0000921114
Armata Pharmaceuticals, Inc.
ARMP
0002028892
Kyme Pierre
5005 MCCONNELL AVENUE
LOS ANGELES
CA
90066
0
1
0
0
Chief Business Officer
Common Stock
10000
D
Stock Options (Right to Buy)
3.38
2034-03-14
Common Stock
40000
D
Twenty-five percent (25%) of the Stock Options shall vest on March 14th of each of 2025, 2026, 2027, and 2028.
/s/ Pierre Kyme
2024-06-28